ABVC BioPharma, Inc. (ABVC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ABVC BioPharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.26x | -1.40x | -0.65x | -1.21x | -6.62x | -10.27x |
| P/B Ratio | 4.46x | 5.62x | 3.24x | 4.44x | 9.60x | 15.24x |
| P/S Ratio | 62.24x | 13.52x | 32.99x | 20.41x | 238.71x | 208.16x |
| Profitability | ||||||
| Gross Margin | 100.0% | 99.9% | -98.1% | 70.5% | 98.6% | 96.1% |
| Operating Margin | -898.5% | -923.3% | -4439.2% | -1558.5% | -3290.1% | -1760.9% |
| Net Margin | -993.6% | -962.1% | -5109.3% | -1693.5% | -3608.5% | -2027.0% |
| EBITDA Margin | -835.0% | -852.2% | -4153.2% | -1567.0% | -3083.7% | -2147.2% |
| Liquidity | ||||||
| Current Ratio | 0.41x | 0.33x | 0.27x | 0.54x | 2.07x | 1.27x |
| Quick Ratio | 0.41x | 0.33x | 0.27x | 0.54x | 2.07x | 1.27x |
| Leverage | ||||||
| Debt/Equity | 0.31x | 2.61x | 1.78x | 0.77x | 0.38x | 1.03x |
YoY = year-over-year change. Source: FMP..